CME/CE
Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD's CME activities. Our topics span cardiology, diabetes, oncology, women's health and more. And our CME library is continuously growing, every quarter.
541-555 of 1027
APOC3 Inhibition: A Novel Approach to Lowering TGs
MinuteCE®APOC3 Inhibition: A Novel Approach to Lowering TGs
Driving Progress in Cardiology: Exploring the Role of FXI in Acute Coronary Syndromes & Beyond
CME/CEDriving Progress in Cardiology: Exploring the Role of FXI in Acute Coronary Syndromes & Beyond
Expert Perspectives From AUA 2025: Contextualizing the Evolving Landscape of Bladder Cancer
CME/CEExpert Perspectives From AUA 2025: Contextualizing the Evolving Landscape of Bladder Cancer
Cracking the Case: A Clinical Consult on Potassium Binders in Patients with Chronic Kidney Disease and Heart Failure
CME/CECracking the Case: A Clinical Consult on Potassium Binders in Patients with Chronic Kidney Disease and Heart Failure
Novel Therapies in Managing Patients With Cardiovascular-Kidney-Metabolic Syndrome and Heart Failure
Broadcast ReplayNovel Therapies in Managing Patients With Cardiovascular-Kidney-Metabolic Syndrome and Heart Failure
Insights from Experts: Preventing and Managing CMV Post-Solid Organ Transplant
CME/CEInsights from Experts: Preventing and Managing CMV Post-Solid Organ Transplant
- advertisement
New Strategies for Individualizing Treatment in DME
CME/CENew Strategies for Individualizing Treatment in DME
From Doctor-Speak to Patient-Speak: Bridging the Communication Gap
CME/CEFrom Doctor-Speak to Patient-Speak: Bridging the Communication Gap
Time Is Bone: Making the Case for Early Anabolic Treatment in Osteoporosis
CME/CETime Is Bone: Making the Case for Early Anabolic Treatment in Osteoporosis
Treatment Advances in Generalized Myasthenia Gravis: A Pathophysiology-Driven Framework Leveraging FcRn Therapeutics
CME/CETreatment Advances in Generalized Myasthenia Gravis: A Pathophysiology-Driven Framework Leveraging FcRn Therapeutics
Enhancing Diagnosis, Treatment, and Outcomes in Paroxysmal Nocturnal Hemoglobinuria with Novel Oral Therapeutics
CME/CEEnhancing Diagnosis, Treatment, and Outcomes in Paroxysmal Nocturnal Hemoglobinuria with Novel Oral Therapeutics
Revolutionizing Diagnostic Precision: AI-Driven Approaches in Digital Pathology and HER2 Expression
CME/CERevolutionizing Diagnostic Precision: AI-Driven Approaches in Digital Pathology and HER2 Expression
- advertisement
New Frontiers in MG: How FcRn Antagonists Are Changing MG Therapy
MinuteCE®New Frontiers in MG: How FcRn Antagonists Are Changing MG Therapy
Preventing Myasthenic Crisis: Early Signs and Critical Interventions
MinuteCE®Preventing Myasthenic Crisis: Early Signs and Critical Interventions
Diagnostic Advances in gMG: Effective Tools and Techniques
MinuteCE®Diagnostic Advances in gMG: Effective Tools and Techniques













































































